Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
8,537
datasets available to search
ShareScore release 0.9.0
Dataset results
8,537 results for “Openness”
An Open-Label, Prospective Study to Assess the Safety and Effectiveness of Adalimumab in Patients With Moderate to Severe Plaque Psoriasis in the Russian Federation
ClinicalTrials.gov study NCT01644396. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Open Label Phase Two Trial of Radium Ra 223 Dichloride With Concurrent Administration of Abiraterone Acetate Plus Prednisone in Symptomatic Castration-Resistant (Hormone-Refractory) Prostate Cancer Su
ClinicalTrials.gov study NCT02097303. IPD Sharing: NO. Countries: 1. Publications: 0.
An Open-label Study of the Effect of Tomivosertib (eFT508) in Patients With Advanced Castrate-resistant Prostate Cancer
ClinicalTrials.gov study NCT03690141. IPD Sharing: NO. Countries: 1. Publications: 0.
Open Label Extension Trial of PDE4 Inhibition With Roflumilast for the Management of Atopic Dermatitis
ClinicalTrials.gov study NCT04804605. IPD Sharing: Not stated. Countries: 2. Publications: 0.
An Open-label Randomized Multicenter Phase III Clinical Study Comparing Safety and Efficacy of Algeron (Cepeginterferon Alfa-2b) and and PegIntron (Peginterferon Alfa-2b) in Combination With Ribavirin
ClinicalTrials.gov study NCT02103439. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Understanding Dexmedetomidine in Neonates After Open Heart Surgery
ClinicalTrials.gov study NCT00576381. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Open-Label Study of Oral Treprostinil in Digital Ulcers
ClinicalTrials.gov study NCT00848107. IPD Sharing: Not stated. Countries: 3. Publications: 0.
An Open-label, Dose Escalation, Pharmacodynamic, Pharmacokinetic, and Effect of Food Phase 1 Study of E7820 to Determine the Maximum Tolerated Dose Following Twice Daily Oral Administration in Subject
ClinicalTrials.gov study NCT01773421. IPD Sharing: Not stated. Countries: 2. Publications: 0.
A 52 Week Open Label Trial of Memantine for Frontotemporal Lobar Degeneration
ClinicalTrials.gov study NCT00187525. IPD Sharing: Not stated. Countries: 0. Publications: 1.
An Open-label follow-on Trial to Assess the Long-term Safety and Efficacy of Oral SPM 927 in Subjects With Diabetic Neuropathy
ClinicalTrials.gov study NCT00861042. IPD Sharing: Not stated. Countries: 0. Publications: 1.
Phase 3, Open-label, Single-dose Study of CSL222 in Adolescent Male Subjects (≥ 12 to < 18 Years of Age) With Severe or Moderately Severe Hemophilia B
ClinicalTrials.gov study NCT07080905. IPD Sharing: YES. Countries: 3. Publications: 0.
A Randomized, Open-label, Single Dose, Parallel Study to Evaluate the Pharmacokinetics Dose Proportionality of GLA5PR GLARS-NF1 Tablet in Healthy Male Volunteers
ClinicalTrials.gov study NCT02327000. IPD Sharing: Not stated. Countries: 0. Publications: 1.
An Actual Use, Open-label Study Assessing Usability of Remote Assist to Program Cochlear Implant Recipients
ClinicalTrials.gov study NCT04987021. IPD Sharing: NO. Countries: 1. Publications: 0.
An Open Label Study That Will Test Safety and Efficacy of RZL-012 Injection Into the Submental Fat in Chinese vs. Non-Chinese Subjects.
ClinicalTrials.gov study NCT05466448. IPD Sharing: NO. Countries: 1. Publications: 0.
Open-label Study of Adalimumab in Japanese Subjects With Hidradenitis Suppurativa
ClinicalTrials.gov study NCT02904902. IPD Sharing: YES. Countries: 1. Publications: 0.
Open-Label Extension of the PTI-125-04 Study in Mild-to-Moderate Alzheimer's Disease
ClinicalTrials.gov study NCT05352763. IPD Sharing: Not stated. Countries: 2. Publications: 0.
An Open Label Study of Levetiracetam Monotherapy in Patients With Newly Diagnosed Focal Epilepsy
ClinicalTrials.gov study NCT01506882. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Open Label Safety Study of Enteric-Coated Spheroid Suspension in Infants Aged Less Than 12 Months With Presumed Gastroesophageal Reflux Disease (GERD)
ClinicalTrials.gov study NCT00868296. IPD Sharing: Not stated. Countries: 11. Publications: 0.
A Phase I/II, Multi-Center, Open-Label, Dose-Escalation, Safety and Efficacy Study of PHY906 Plus Capecitabine in Patients With Advanced Pancreatic Carcinoma
ClinicalTrials.gov study NCT00411762. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Open Label, Randomized Study of Low Concentration Ioforminol Injections for Use in Abdominal CECT in Healthy Volunteers
ClinicalTrials.gov study NCT01672996. IPD Sharing: Not stated. Countries: 1. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.